Bivalent second booster dose of the COVID-19 vaccine: Eligible populations’ reasons for receiving in Italy

References

• Kandeel M, Mohamed MEM, Abd El-Lateef HM, Venugopala KN, El-Beltagi HS. Omicron variant genome evolution and phylogenetics. J Med Virol. 2022;94(4):1627–7. doi:10.1002/jmv.27515.
   PubMed Web of Science ®Google Scholar
• Yadav P, Mohandas S, Sarkale P, Nyayanit D, Shete A, Sahay R, Potdar V, Baradkar S, Gupta N, Sapkal G, et al. Isolation of SARS-CoV-2 B.1.1.28.2 (P2) variant and pathogenicity comparison with D614G variant in hamster model. J Inf Pub Health. 2022;15(2):164–71. doi:10.1016/j.jiph.2021.12.009.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. SARS-CoV-2 variants of concern as of 10 November 2022. [accessed 2022 Dec 18]. https://www.ecdc.europa.eu/en/covid-19/variants-concern.
   Google Scholar
• World Health Organization. Weekly epidemiological update on COVID-19 - 16 November 2022. [accessed 2022 Dec 18]. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19—16-november-2022.
   Google Scholar
• Hu J, Peng P, Cao X, Wu K, Chen J, Wang K, Tang N, Huang AL. Increased immune escape of the new sars-cov-2 variant of concern omicron. Cell Mol Immunol. 2022;19(2):293–5. doi:10.1038/s41423-021-00836-z.
   PubMed Web of Science ®Google Scholar
• Ito K, Piantham C, Nishiura H. Relative instantaneous reproduction number of omicron sars-cov-2 variant with respect to the delta variant in Denmark. J Med Virol. 2022;94(5):2265–8. doi:10.1002/jmv.27560.
   PubMed Web of Science ®Google Scholar
• Lundberg AL, Lorenzo-Redondo R, Ozer EA, Hawkins CA, Hultquist JF, Welch SB, Prasad PVV, Oehmke JF, Achenbach CJ, Murphy RL, et al. Has omicron changed the evolution of the pandemic? JMIR Public Health Surveill. 2022;8(1):35763. doi:10.2196/35763.
   Google Scholar
• Ministero della Salute. Circolare n.40319. Aggiornamento delle indicazioni sull’utilizzo dei vaccini a m-RNA bivalenti. [accessed 2022 Dec 18]. https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2022&codLeg=89142&parte=1%20&serie=null.
   Google Scholar
• Ministero della Salute. Report vaccini anti COVID-19. [accessed 2023 Feb 9]. https://www.governo.it/it/cscovid19/report-vaccini/.
   Google Scholar
• Centers for Disease Control (CDC). COVID data tracker. [accessed 2023 Feb 9]. https://covid.cdc.gov/covid-data-tracker.
   Google Scholar
• Chalkias S, Harper C, Vrbicky K, Walsh SR, Essink B, Brosz A, McGhee N, Tomassini JE, Chen X, Chang Y, et al. A bivalent omicron-containing booster vaccine against Covid-19. N Engl J Med. 2022;387(14):1279–91. doi:10.1056/NEJMoa2208343.
   PubMed Web of Science ®Google Scholar
• Thompson MG, Natarajan K, Irving SA, Rowley EA, Griggs EP, Gaglani M, Klein NP, Grannis SJ, DeSilva MB, Stenehjem E, et al. Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of delta and omicron variant predominance - VISION Network, 10 States, August 2021–January 2022. Morb Mortal Wkly Rep. 2022;71(4):139–45. doi:10.15585/mmwr.mm7104e3.
   PubMed Web of Science ®Google Scholar
• Costa Clemens SA, Weckx L, Clemens R, Almeida Mendes AV, Ramos Souza A, Silveira MBV, da Guarda SNF, de Nobrega MM, de Moraes Pinto MI, Gonzalez IGS, et al. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study. Lancet. 2022;399(10324):521–9. doi:10.1016/S0140-6736(22)00094-0.
   PubMed Web of Science ®Google Scholar
• Cheng SMS, Mok CKP, Leung YWY, Ng SS, Chan KCK, Ko FW, Chen C, Yiu K, Lam BHS, Lau EHY, et al. Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination. Nat Med. 2022;28(3):486–9. doi:10.1038/s41591-022-01704-7.
   PubMed Web of Science ®Google Scholar
• Galanis P, Vraka I, Katsiroumpa A, Siskou O, Konstantakopoulou O, Katsoulas T, Mariolis-Sapsakos T, Kaitelidou D. Predictors of willingness of the general public to receive a second COVID-19 booster dose or a new COVID-19 vaccine: a cross-sectional study in Greece. Vaccines (Basel). 2022;10(7):1061. doi:10.3390/vaccines10071061.
   PubMed Web of Science ®Google Scholar
• Babicki M. Will bivalent vaccination against COVID-19 increase the desire for COVID-19 vaccination among Poles? Vaccines (Basel). 2022;10(10):1658. doi:10.3390/vaccines10101658.
   PubMed Web of Science ®Google Scholar
• Di Giuseppe G, Pelullo CP, Della Polla G, Pavia M, Angelillo IF. Exploring the willingness to accept SARS-CoV-2 vaccine in a university population in Southern Italy, September to November 2020. Vaccines (Basel). 2021;9(3):275. doi:10.3390/vaccines9030275.
   PubMed Web of Science ®Google Scholar
• Di Giuseppe G, Pelullo CP, Della Polla G, Montemurro MV, Napolitano F, Pavia M, Angelillo IF. Surveying willingness toward SARS-CoV-2 vaccination of healthcare workers in Italy. Expert Rev Vaccines. 2021;20(7):881–9. doi:10.1080/14760584.2021.1922081.
   PubMed Web of Science ®Google Scholar
• Della Polla G, Pelullo CP, Di Giuseppe G, Angelillo IF. Changes in behaviors and attitudes in response to COVID-19 pandemic and vaccination in healthcare workers and university students in Italy. Vaccines (Basel). 2021;9(11):1276. doi:10.3390/vaccines9111276.
   PubMed Web of Science ®Google Scholar
• Bianco A, Della Polla G, Angelillo S, Pelullo CP, Licata F, Angelillo IF. Parental COVID-19 vaccine hesitancy: a cross-sectional survey in Italy. Expert Rev Vaccines. 2022;21(4):541–7. doi:10.1080/14760584.2022.2023013.
   PubMed Web of Science ®Google Scholar
• Corea F, Folcarelli L, Napoli A, Miraglia del Giudice G, Angelillo IF. The impact of COVID-19 vaccination in changing the adherence to preventive measures: evidence from Italy. Vaccines (Basel). 2022;10(5):777. doi:10.3390/vaccines10050777.
   PubMed Web of Science ®Google Scholar
• Miraglia del Giudice G, Folcarelli L, Napoli A, Corea F, Angelillo IF, Collaborative Working Group. COVID-19 vaccination hesitancy and willingness among pregnant women in Italy. Front Public Health. 2022;10:995382. doi:10.3389/fpubh.2022.995382.
   PubMed Web of Science ®Google Scholar
• Folcarelli L, Miraglia del Giudice G, Corea F, Angelillo IF. Intention to receive the COVID-19 vaccine booster dose in a university community in Italy. Vaccines (Basel). 2022;10(2):146. doi:10.3390/vaccines10020146.
   PubMed Web of Science ®Google Scholar
• Napoli A, Miraglia del Giudice G, Corea F, Folcarelli L, Angelillo IF. Parents’ reasons to vaccinate their children aged 5–11 years against COVID-19 in Italy. Front Med (Lausanne). 2022;9:949693. doi:10.3389/fmed.2022.949693.
   PubMed Web of Science ®Google Scholar
• Miraglia del Giudice G, Napoli A, Corea F, Folcarelli L, Angelillo IF. Evaluating COVID-19 vaccine willingness and hesitancy among parents of children aged 5–11 years with chronic conditions in Italy. Vaccines (Basel). 2022;10(3):396. doi:10.3390/vaccines10030396.
   PubMed Web of Science ®Google Scholar
• Della Polla G, Miraglia del Giudice G, Folcarelli L, Napoli A, Angelillo IF, Collaborative Working Group. Willingness to accept a second COVID-19 vaccination booster dose among healthcare workers in Italy. Front Public Health. 2022;10:1051035. doi:10.3389/fpubh.2022.1051035.
   PubMed Web of Science ®Google Scholar
• Della Polla G, Miraglia del Giudice G, Napoli A, Folcarelli L, Angelillo IF. COVID-19 vaccination among a population experiencing homelessness: a survey in Italy. Vaccines (Basel). 2022;10(12):2118. doi:10.3390/vaccines10122118.
   PubMed Web of Science ®Google Scholar
• Polverino F, Stern DA, Ruocco G, Balestro E, Bassetti M, Candelli M, Cirillo B, Contoli M, Corsico A, D’Amico F, et al. Comorbidities, cardiovascular therapies, and COVID-19 mortality: a nationwide, Italian observational study (ItaliCO). Front Cardiovasc Med. 2020;7:585866. doi:10.3389/fcvm.2020.585866. Erratum in: Front Cardiovasc Med. 2020;7:631602.
   PubMed Web of Science ®Google Scholar
• Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, Tobin KA, Cerfolio RJ, Francois F, Horwitz LI. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. doi:10.1136/bmj.m1966.
   PubMed Web of Science ®Google Scholar
• Reyes-Sánchez F, Basto-Abreu A, Torres-Alvarez R, Canto-Osorio F, González-Morales R, Dyer-Leal DD, López-Ridaura R, Zaragoza-Jiménez CA, Rivera JA, Barrientos-Gutiérrez T. Fraction of COVID-19 hospitalizations and deaths attributable to chronic diseases. Prev Med. 2022;155:106917. doi:10.1016/j.ypmed.2021.106917.
   PubMed Web of Science ®Google Scholar
• Flythe JE, Assimon MM, Tugman MJ, Chang EH, Gupta S, Shah J, Sosa MA, Renaghan AD, Melamed ML, Wilson FP, et al. Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States. Am J Kidney Dis. 2021;77(2):190–203.e1. doi:10.1053/j.ajkd.2020.09.003.
   PubMed Web of Science ®Google Scholar
• Ishimaru T, Okawara M, Ando H, Hino A, Nagata T, Tateishi S, Tsuji M, Matsuda S, Fujino Y, CORoNaWork Project. Gender differences in the determinants of willingness to get the COVID-19 vaccine among the working-age population in Japan. Hum Vaccin Immunother. 2021;17(11):3975–81. doi:10.1080/21645515.2021.1947098.
   PubMed Web of Science ®Google Scholar
• Lin Y, Huang Z, Xu X, Du W, Alias H, Hu Z, Wong LP. Multi-dimensional psychosocial factors influencing the willingness to receive a COVID-19 vaccine booster: a survey among the public in Mainland China. Hum Vaccin Immunother. 2022;18(6):2126667. doi:10.1080/21645515.2022.2126667.
   PubMed Web of Science ®Google Scholar
• Feng H, Zhu H, Zhang H, Cao L, Li L, Wang J, Huang Y, Lai X, Lyu Y, Jing R, et al. Caregivers’ intentions to COVID-19 vaccination for their children in China: a cross-sectional survey. Hum Vaccin Immunother. 2021;17(12):4799–805. doi:10.1080/21645515.2021.1985355.
   PubMed Web of Science ®Google Scholar
• Szmyd B, Karuga FF, Bartoszek A, Staniecka K, Siwecka N, Bartoszek A, Błaszczyk M, Radek M. Attitude and behaviors towards SARS-CoV-2 vaccination among healthcare workers: a cross-sectional study from Poland. Vaccines (Basel). 2021;9(3):218. doi:10.3390/vaccines9030218.
   PubMed Web of Science ®Google Scholar
• Leng A, Maitland E, Wang S, Nicholas S, Liu R, Wang J. Individual preferences for COVID-19 vaccination in China. Vaccine. 2021;39(2):247–54. doi:10.1016/j.vaccine.2020.12.009.
   PubMed Web of Science ®Google Scholar
• Wong LP, Alias H, Siaw YL, Muslimin M, Lai LL, Lin Y, Hu Z. Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia. Hum Vaccin Immunother. 2022;18(5):2078634. doi:10.1080/21645515.2022.2078634.
   PubMed Web of Science ®Google Scholar
• Mangat C, Rich J, Sanghavi D, Schmidt R, Milosavljevic N, Linh T, Bansal P. Parents’ perspective on COVID-19 vaccine in children 6 months through 4 years: a cross-sectional study from Northwest Wisconsin. BMJ Open. 2022;12(9):e065453. doi:10.1136/bmjopen-2022-065453.
   PubMed Web of Science ®Google Scholar
• To QG, Stanton R, Khalesi S, Williams SL, Alley SJ, Thwaite TL, Fenning AS, Vandelanotte C. Willingness to vaccinate against COVID-19 declines in Australia, except in lockdown areas. Vaccines (Basel). 2021;9(5):479. doi:10.3390/vaccines9050479.
   PubMed Web of Science ®Google Scholar
• Cunningham-Erves J, Mayer CS, Han X, Fike L, Yu C, Tousey PM, Schlundt DG, Gupta DK, Mumma MT, Walkley D, et al. Factors influencing intent to receive COVID-19 vaccination among black and white adults in the southeastern United States, October–December 2020. Hum Vaccin Immunother. 2021;17(12):4761–98. doi:10.1080/21645515.2021.1984134.41.
   PubMed Web of Science ®Google Scholar
• Di Giuseppe G, Pelullo CP, Volgare AS, Napolitano F, Pavia M. Parents’ willingness to vaccinate their children with COVID-19 vaccine: results of a survey in Italy. J Adolesc Health. 2022;70(4):550–8. doi:10.1016/j.jadohealth.2022.01.003.
   PubMed Web of Science ®Google Scholar
• Mărcău FC, Gheorghițoiu R, Bărbăcioru IC. Survey upon the reasons of COVID-19 vaccination acceptance in Romania. Vaccines (Basel). 2022;10(10):1679. doi:10.3390/vaccines10101679.
   PubMed Web of Science ®Google Scholar
• Jang SR, Lee SK, Connelly S. Understanding motivations and deterrents for COVID-19 vaccination among US working adults: a mixed method approach. Hum Vaccin Immunother. 2022;18(6):2132752. doi:10.1080/21645515.2022.2132752.
   PubMed Web of Science ®Google Scholar
• Williams L, Gallant A, Brown L, Corrigan K, Crowe K, Hendry E. Barriers and facilitators to the future uptake of regular COVID-19 booster vaccinations among young adults in the UK. Hum Vaccin Immunother. 2022;18(6):2129238. doi:10.1080/21645515.2022.2129238.
   PubMed Web of Science ®Google Scholar
• Benis A, Seidmann A, Ashkenazi S. Reasons for taking the COVID-19 vaccine by US social media users. Vaccines (Basel). 2021;9(4):315. doi:10.3390/vaccines9040315.
   PubMed Web of Science ®Google Scholar
• Wu J, Li Q, Silver Tarimo C, Wang M, Gu J, Wei W, Ma M, Zhao L, Mu Z, Miao Y. COVID-19 vaccine hesitancy among Chinese population: a large-scale national study. Front Immunol. 2021;12:781161. doi:10.3389/fimmu.2021.781161.
   PubMed Web of Science ®Google Scholar
• Wang K, Wong EL, Cheung AW, Yau PS, Chung VC, Wong CH, Dong D, Wong SY, Yeoh EK. Influence of vaccination characteristics on COVID-19 vaccine acceptance among working-age people in Hong Kong, China: a discrete choice experiment. Front Public Health. 2021;9:793533. doi:10.3389/fpubh.2021.793533.
   PubMed Web of Science ®Google Scholar
• Bartoš V, Bauer M, Cahlíková J, Chytilová J. Communicating doctors’ consensus persistently increases COVID-19 vaccinations. Nature. 2022;606(7914):542–9. doi:10.1038/s41586-022-04805-y.
   PubMed Web of Science ®Google Scholar
• Davis TC, Beyl R, Bhuiyan MAN, Davis AB, Vanchiere JA, Wolf MS, Arnold CL. COVID-19 concerns, vaccine acceptance and trusted sources of information among patients cared for in a safety-net health system. Vaccines (Basel). 2022;10(6):928. doi:10.3390/vaccines10060928.
   PubMed Web of Science ®Google Scholar
• Akesson J, Weiss ES, Sae-Hau M, Gracia G, Lee M, Culp L, Connell B, Butterfield S, Conti RM. COVID-19 vaccine–related beliefs and behaviors among patients with and survivors of hematologic malignancies. JCO Oncol Pract. 2022;19(2):OP2200338. doi:10.1200/OP.22.00338.
   Google Scholar
• Sousa ÁFL, Teixeira JRB, Lua I, de Oliveira Souza F, Ferreira AJF, Schneider G, de Carvalho HEF, de Oliveira LB, Lima SVMA, de Sousa AR, et al. Determinants of COVID-19 vaccine hesitancy in Portuguese-speaking countries: a structural equations modeling approach. Vaccines (Basel). 2021;9(10):1167. doi:10.3390/vaccines9101167.
   PubMed Web of Science ®Google Scholar
• Pakalniškienė V, Kairys A, Jurkuvėnas V, Mikuličiūtė V, Ivleva V. Could belief in fake news predict vaccination behavior in the elderly? Int J Environ Res Public Health. 2022;19(22):14901. doi:10.3390/ijerph192214901.
   PubMed Web of Science ®Google Scholar
• Singh K, Lima G, Cha M, Cha C, Kulshrestha J, Ahn YY, Varol O. Misinformation, believability, and vaccine acceptance over 40 countries: takeaways from the initial phase of the COVID-19 infodemic. PLoS One. 2022;17(2):e0263381. doi:10.1371/journal.pone.0263381.
   PubMed Web of Science ®Google Scholar
• Souan L, Sughayer MA, Abu Alhowr M, Ammar K, Bader SA. An update on the impact of SARS-CoV-2 pandemic public awareness on cancer patients’ COVID-19 vaccine compliance: outcomes and recommendations. Front Public Health. 2022;10:923815. doi:10.3389/fpubh.2022.923815.
   PubMed Web of Science ®Google Scholar